Vivakor (VIVK) - EPS (earnings per share)

EPS in 2026 (TTM): NZ-$14,975

According to Vivakor's latest financial reports the company's current EPS (TTM) is NZ-$15,471. In 2025 the company made an earnings per share (EPS) of NZ-$11,345 a decrease over its 2024 EPS that were of NZ-$5,398.

EPS history for Vivakor from 2007 to 2026

Annual EPS

Year	EPS	Change
2026 (TTM)	NZ-$14,975	32%
2025	NZ-$11,345	110.16%
2024	NZ-$5,398	35.11%
2023	NZ-$3,995	-54.1%
2022	NZ-$8,704	165.22%
2021	NZ-$3,282	99.99%
2020	NZ-$1,641
2009	NZ-$684,398	49.23%
2008	NZ-$458,616	4916.88%
2007	NZ-$9,141

EPS for similar companies or competitors

Company	EPS	EPS differencediff.	Country
Merrimack Pharmaceuticals MACK	NZ$24.72	-100.16%	🇺🇸 USA
Exact Sciences EXAS	NZ-$9.49	-99.94%	🇺🇸 USA
AVEO Oncology AVEO	NZ-$1.50	-99.99%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Vivakor (VIVK)

EPS in 2026 (TTM): NZ-$14,975